Stock turmoil in Hong Kong | Sanse Pharmaceutical (01530.HK) fell more than 4% with Pfizer licensing agreement effective, offering a 17.09% discount to issue new shares to raise 785 million Hong Kong dollars.

According to the Wise News Finance APP, Sanse Pharmaceutical (01530.HK) fell more than 4%, as of the time of publication, it fell by 4.44%, to 29.05 Hong Kong dollars, with a trading volume of 525 million Hong Kong dollars.